Key facts
| Price (PPV) | 683 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | olodatéroltiotropium |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03AL06 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boite unitaire |
| Hospital price | 454 MAD |
| Data collected on | 9/8/2026 |
Indications
SPIOLTO RESPIMAT est indiqué en traitement bronchodilatateur continu destiné à soulager les symptômes des patients adultes présentant une bronchopneumopathie chronique obstructive (BPCO).
Find an open pharmacy
On-call pharmacies near you
About Spiolto Respimat 2.5 µg / 2.4 µg/ Dose
Spiolto Respimat 2.5 µg / 2.4 µg/ Dose belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Spiolto Respimat 2.5 µg / 2.4 µg/ Dose, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Spiolto Respimat 2.5 µg / 2.4 µg/ Dose
Answers to common questions from Moroccan patients about this drug.